1. Data from initial 6 month endpoint of GOLIATH study, XPS results in a lower rate of early reinterventions but has a similar rate after 6 months. Bachmann A, et al. "180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study." European Urology 65.5 (2014): 931-42. Web.
2. Jovanovic, M., Zoran Dzamic, Miodrag Acimovic, Boris Kajmakovic, and Tomislav Pejcic. "Usage of GreenLight HPS 180-W Laser Vaporisation for Treatment of Benign Prostatic Hyperplasia." ACTA CHIR IUG Acta Chirurgica Iugoslavica Acta Chir Iugo ACTA CHIR IUGOSL 61.1 (2014): 57-61. Web.
Ad Statistics
Times Displayed: 49690
Times Visited: 1410 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
3. "Prostate Enlargement: Benign Prostatic Hyperplasia." Prostate Enlargement: Benign Prostatic Hyperplasia. National Institute of Diabetes and Digestive and Kidney Diseases, 1 Sept. 2014. Web. 10 June 2016.
4. Barry, Md M., and Md C. Roehrborn. "Management of Benign Prostatic Hyperplasia." Annual Review of Medicine Annu. Rev. Med. 48.1 (1997): 177-89. Print.
5. Benign enlargement of prostate. ADAM Health Illustrated Encyclopedia. http://www.healthline.com/adamcontent/enlarged-prostate. Accessed Oct. 21, 2010.
6. NICE guidance, 'GreenLight XPS for treating benign prostatic hyperplasia', www.nice.org.uk/mtg29.
Back to HCB News
